Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency Transcript [Seeking Alpha]
Jefferies Financial Group Inc. (JEF)
Last jefferies financial group inc. earnings: 10/25 04:42 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Company Participants Holly Manning - Vice President of Investor Relations & External Communications John Evans - CEO & Director Amy Simon - Chief Medical Officer Giuseppe Ciaramella - President Conference Call Participants Jeffrey Teckman Adhirath Sikand - Evercore ISI Institutional Equities, Research Division Maurice Raycroft - Jefferies LLC, Research Division Samantha Semenkow - Citigroup Inc., Research Division Eric Schmidt - Cantor Fitzgerald & Co., Research Division Lut Ming Cheng - JPMorgan Chase & Co, Research Division Yanan Zhu - Wells Fargo Securities, LLC, Research Division Mani Foroohar - Leerink Partners LLC, Research Division Luca Issi - RBC Capital Markets, Research Division Angela Qian - Canaccord Genuity Corp., Research Division Myles Minter - William Blair & Company L.L.C., Research Division Presentation Operator Good morning, and welcome to Beam Therapeutics Conference Call. [Operator Instructions] Please be advised that this ca
Show less
Read more
Impact Snapshot
Event Time:
JEF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JEF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JEF alerts
High impacting Jefferies Financial Group Inc. news events
Weekly update
A roundup of the hottest topics
JEF
News
- Jefferies Financial Group (JEF) had its price target lowered by The Goldman Sachs Group, Inc. from $54.00 to $47.00. They now have a "buy" rating on the stock.MarketBeat
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jefferies Financial Group Inc. - JEFPR Newswire
- Robosense Technology Co., Ltd (RBSTF) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Jefferies (NYSE:JEF) Exceeds Q1 CY2026 Expectations [Yahoo! Finance]Yahoo! Finance
JEF
Earnings
- 3/25/26 - Miss
JEF
Sec Filings
- 3/26/26 - Form 424B2
- 3/25/26 - Form 424B2
- 3/25/26 - Form 424B2
- JEF's page on the SEC website